E-LIB Suche - Ergebnisse für: Colman, Ruben J.

1

INFLIXIMAB AND VEDOLIZUMAB HAVE SIMILAR CLINICAL AND SAFETY..:

Elknawy, Essam ; Rosen, Michael ; Colman, Ruben.
Inflammatory Bowel Diseases. 30 (2024) Supplement_1 - p. S72-S72 , 2024

Link: https://doi.org/10.1093/..

2

Precise infliximab exposure and pharmacodynamic control to ..:

Minar, Phillip Paul ; Colman, Ruben J ; Zhang, Nanhua..
BMJ Open. 14 (2024) 3 - p. e077193 , 2024

Link: https://doi.org/10.1136/..

3

Infliximab Monotherapy vs Combination Therapy for Pediatric..:

Colman, Ruben J ; Vuijk, Stephanie A ; Mathôt, Ron A A...
Inflammatory Bowel Diseases. , 2024

Link: https://doi.org/10.1093/..

4

INFLIXIMAB AND VEDOLIZUMAB HAVE SIMILAR CLINICAL AND SAFETY..:

Elknawy, Essam ; Rosen, Michael ; Colman, Ruben.
Gastrointestinal Endoscopy. 99 (2024) 6 - p. AB1086-AB1087 , 2024

Link: https://doi.org/10.1016/..

5

Operating Properties of Disease Activity Indices in Pediatr..:

Colman, Ruben J ; Solitano, Virginia ; MacDonald, John K...
Inflammatory Bowel Diseases. , 2024

Link: https://doi.org/10.1093/..

6

Infliximab Therapy for Pediatric Crohn Disease and Ulcerati..:

, In: Pediatric Inflammatory Bowel Disease,

Colman, Ruben J. ; Dykes, Dana M. H. ; Arce-Clachar, Ana Catalina.. - p. 407-422 , 2023

Link: https://doi.org/10.1007/..

7

Sa1806 HLA-DQA1*05 GENOTYPE AND ANTI-TNF IMMUNOGENICITY: A ..:

Solitano, Virginia ; Facciorusso, Antonio ; Nguyen, Tran M....
Gastroenterology. 164 (2023) 6 - p. S-439 , 2023

Link: https://doi.org/10.1016/..

8

Editorial: achievements and unresolved questions in improvi..:

Colman, Ruben J. ; Minar, Phillip
Alimentary Pharmacology & Therapeutics. 57 (2023) 5 - p. 567-568 , 2023

Link: https://doi.org/10.1111/..

9

PREDICTIVE PERFORMANCE OF DIFFERENT POPULATION PHARMACOKINE..:

Samuels, Abigail ; Punt, Nieko ; Reifenberg, Jack...
Inflammatory Bowel Diseases. 28 (2022) Supplement_1 - p. S99-S100 , 2022

Link: https://doi.org/10.1093/..

10

Model-informed Precision Dosing for Biologics Is Now Availa..:

Colman, Ruben J ; Samuels, Abigail ; Mizuno, Tomoyuki...
Inflammatory Bowel Diseases. 29 (2022) 8 - p. 1342-1346 , 2022

Link: https://doi.org/10.1093/..

11

Su1585: BIOMARKERS OF DRUG CLEARANCE IN PEDIATRIC IBD – A R..:

Colman, Ruben J. ; Mizuno, Tomoyuki ; Hyams, Jeffrey S....
Gastroenterology. 162 (2022) 7 - p. S-641 , 2022

Link: https://doi.org/10.1016/..

12

REAL-WORLD VEDOLIZUMAB PHARMACOKINETIC STUDY IN CHILDREN ID..:

Colman, Ruben ; Mizuno, Tomoyuki ; Hyams, Jeffrey...
Inflammatory Bowel Diseases. 28 (2022) Supplement_1 - p. S100-S100 , 2022

Link: https://doi.org/10.1093/..

13

REAL-WORLD VEDOLIZUMAB PHARMACOKINETIC STUDY IN CHILDREN ID..:

Colman, Ruben ; Mizuno, Tomoyuki ; Hyams, Jeffrey...
Gastroenterology. 162 (2022) 3 - p. S100 , 2022

Link: https://doi.org/10.1053/..

14

Real world population pharmacokinetic study in children and..:

Colman, Ruben J. ; Mizuno, Tomoyuki ; Fukushima, Keizo...
Alimentary Pharmacology & Therapeutics. 57 (2022) 5 - p. 524-539 , 2022

Link: https://doi.org/10.1111/..

15

Tu1653: MODEL-INFORMED PRECISION DOSING WITH A PK DASHBOARD..:

Minar, Phillip P. ; Samuels, Abigail ; Colman, Ruben J....
Gastroenterology. 162 (2022) 7 - p. S-1023 , 2022

Link: https://doi.org/10.1016/..